Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| DENSO Corporation | BZAI Blaize Holdings, Inc. | 13G/A | 0% | Mar 26, 2026 | 6mo |
| JONATHAN H. DORFMAN | QVCAQ QVC Group, Inc. | 13G | 5.15% | Mar 16, 2026 | 6mo |
| Fourthstone LLC | FMBM F&M Bank Corp | 13G/A | 9.98% | Mar 13, 2026 | 6mo |
| WP XI Partners, L.P. | SHC Sotera Health Co | 13G/A | 0% | Mar 6, 2026 | 6mo |
| Extract Advisors LLC | NEXM NexMetals Mining Corp. | 13G/A | 5.4% | Mar 2, 2026 | 6mo |
| MILLENNIUM MANAGEMENT LLC | FTH Faeth Therapeutics, Inc. | 13G | 9.6% | Feb 24, 2026 | 6mo |
| Samsara BioCapital, L.P. | STRO Sutro Biopharma, Inc. | 13G | 6.4% | Feb 11, 2026 | 6mo |
| John D. Halpern | ERNA Ernexa Therapeutics Inc. | 13G/A | 5.6% | Feb 10, 2026 | 6mo |
| Freebird Partners LP | ERNA Ernexa Therapeutics Inc. | 13G/A | 9.9% | Feb 10, 2026 | 6mo |
| Brian Matthew Bloom | MSLE Satellos Bioscience Inc. | 13G | 7.35% | Feb 6, 2026 | 6mo |
| Sumitomo Mitsui Banking Corporation | PSNY Polestar Automotive Holding UK PLC | 13G | 7.1% | Feb 5, 2026 | 6mo |
| RP Investment Advisors LP | BIII Black Spade Acquisition III Co | 13G/A | 8.3% | Feb 4, 2026 | 6mo |
| Nathan Leight | ALOV Aldabra 4 Liquidity Opportunity Vehicle, Inc. | 13G | 19.8% | Jan 21, 2026 | 6mo |
| IAN T BOTHWELL | ZEOX Zeo ScientifiX, Inc. | 13D/A | 14.7% | Jan 14, 2026 | 6mo |
| Aquamarine Financial (Cayman) Ltd | ORMP Oramed Pharmaceuticals Inc. | 13G | 5.06% | Jan 14, 2026 | 6mo |
| Divisadero Street Capital Management, LP | SGHC Super Group (SGHC) Ltd | 13G | 6.1% | Jan 13, 2026 | 6mo |
| Saturn V Capital Management LP | MNPR Monopar Therapeutics | 13G | 5.2% | Jan 5, 2026 | 6mo |
| BROWN ADVISORY INC | ESTA Establishment Labs Holdings Inc. | 13G/A | 5.38% | Dec 31, 2025 | 6mo |
| Fund 1 Investments, LLC | SFIX Stitch Fix, Inc. | 13G/A | 1.62% | Dec 31, 2025 | 6mo |
| Lynx1 Capital Management LP | ALLO Allogene Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2025 | 6mo |
| Anson Funds Management LP | REKR Rekor Systems, Inc. | 13G/A | 4.9% | Dec 31, 2025 | 6mo |
| Driehaus Capital Management LLC | XENE Xenon Pharmaceuticals Inc. | 13G/A | 4.87% | Dec 31, 2025 | 6mo |
| Pomeroy Scott | XTIA XTI Aerospace, Inc. | 13D | 6.26% | Dec 30, 2025 | 6mo |
| Anson Funds Management LP | VLOS Velos Acquisition I Corp. | 13G/A | 0.2% | Dec 8, 2025 | 6mo |
| ALTA FOX OPPORTUNITIES FUND, LP | XPEL XPEL, Inc. | 13G/A | 7% | Nov 20, 2025 | 6mo |
| Rubric Capital Management LP | EDSA Edesa Biotech, Inc. | 13G | 7.74% | Mar 31, 2025 | 6mo |
| G1 Execution Services, LLC | CORZ Core Scientific, Inc. | 13G/A | 4.6% | Mar 31, 2025 | 6mo |
| G1 Execution Services, LLC | COIN Coinbase Global, Inc. | 13G/A | 4.2% | Mar 31, 2025 | 6mo |
| He Zhengxu | CYH Community Health Systems Inc | 13G | 5.3% | May 14, 2026 | 6mo |
| Leviticus Partners LP | UEIC Universal Electronics Inc | 13G/A | 4.9% | May 14, 2026 | 6mo |
| BIOGEN INC. | APLS Apellis Pharmaceuticals, Inc. | 13D/A | 0% | May 14, 2026 | 6mo |
| Mink Brook Asset Management LLC | CHRN ChronoScale Holdings Corp | 13G/A | 0% | May 14, 2026 | 6mo |
| Deerfield Management Company, L.P. | INSP Inspire Medical Systems, Inc. | 13G/A | 4.5% | May 14, 2026 | 6mo |
| Saba Capital Management, L.P. | ASA ASA Gold & Precious Metals Ltd | 13D/A | 31.91% | May 13, 2026 | 6mo |
| Alexandra Seros | EVC Entravision Communications Corp | 13D/A | 12.18% | May 13, 2026 | 6mo |
| North Run Strategic Opportunities Fund I, LP | LPTH Lightpath Technologies Inc | 13D/A | 14.7% | May 13, 2026 | 6mo |
| RIVER & MERCANTILE ASSET MANAGEMENT LLP | MXCT Maxcyte, Inc. | 13D | 6.1% | May 13, 2026 | 6mo |
| Harraden Circle Investments, LLC | CAEP Cantor Equity Partners III, Inc. | 13G | 14.25% | May 12, 2026 | 6mo |
| Monex Group, Inc. | CNCK Coincheck Group N.V. | 13D/A | 83.6% | May 12, 2026 | 6mo |
| BCLS II Investco, LP | NAMS NewAmsterdam Pharma Co N.V. | 13D/A | 0.1% | May 12, 2026 | 6mo |
| Ramaswamy Vivek | BZFD BuzzFeed, Inc. | 13D | 0% | May 12, 2026 | 6mo |
| Avoro Capital Advisors LLC | WHWK Whitehawk Therapeutics, Inc. | 13D/A | 19.99% | May 12, 2026 | 6mo |
| Redmile Group, LLC | ATRA Atara Biotherapeutics, Inc. | 13D/A | 9.9% | May 12, 2026 | 6mo |
| 8 Rivers Capital, LLC | NPWR Net Power Inc. | 13D/A | 19.5% | May 12, 2026 | 6mo |
| ICAHN CARL C | JBLU Jetblue Airways Corp | 13D/A | 6.72% | May 12, 2026 | 6mo |
| BML Investment Partners, L.P. | ENGN enGene Therapeutics Inc. | 13G/A | 9.95% | May 12, 2026 | 6mo |
| David A. Lorber | PFX PhenixFIN Corp | 13D/A | 12.9% | May 12, 2026 | 6mo |
| Cerberus Capital Management II, L.P. | EOSE Eos Energy Enterprises, Inc. | 13D/A | 32% | May 12, 2026 | 6mo |
| RA CAPITAL MANAGEMENT, L.P. | HOWL Werewolf Therapeutics, Inc. | 13D/A | 12.6% | May 12, 2026 | 6mo |
| STARTEEPO Invest, investicni fond s promennym zakladnim kapitalem, a.s. | XRX Xerox Holdings Corp | 13D | 3.98% | May 12, 2026 | 6mo |